New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts

Morten Persson, Palle Damkjær Rasmussen, Jacob Madsen, Michael Ploug, Andreas Kjaer

35 Citations (Scopus)

Fingerprint

Dive into the research topics of 'New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences